{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T07:40:15Z","timestamp":1733038815168,"version":"3.30.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jpba.2024.116560","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T22:47:37Z","timestamp":1730760457000},"page":"116560","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of protein impurities in Ademetionine 1,4-Butanedisulfonate"],"prefix":"10.1016","volume":"253","author":[{"given":"Yangrui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengting","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lushan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpba.2024.116560_bib1","first-page":"167","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol."},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib3","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jpba.2024.116560_bib5","article-title":"The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives","volume":"12","author":"Zu","year":"2021","journal-title":"Front Pharmcol."},{"issue":"2","key":"10.1016\/j.jpba.2024.116560_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-018-0475-8","article-title":"Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases","volume":"25","author":"Chen","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.jpba.2024.116560_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","article-title":"S-adenosylmethionine metabolism and liver disease","volume":"12","author":"Mato","year":"2013","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.jpba.2024.116560_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","article-title":"S-Adenosylmethionine","volume":"32","author":"Lu","year":"2000","journal-title":"Int J. Biochem Cell Biol."},{"issue":"4","key":"10.1016\/j.jpba.2024.116560_bib10","first-page":"299","article-title":"Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy","volume":"22","author":"Zhou","year":"2014","journal-title":"Zhonghua Gan Zang Bing. Za Zhi"},{"issue":"5","key":"10.1016\/j.jpba.2024.116560_bib11","first-page":"573","article-title":"Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid","volume":"24","author":"Balistreri","year":"1997","journal-title":"J. Pediatr Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s42003-022-03280-5","article-title":"Excess S-adenosylmethionine inhibits methylation via catabolism to adenine","volume":"5","author":"Fukumoto","year":"2022","journal-title":"Commun. Biol."},{"issue":"12","key":"10.1016\/j.jpba.2024.116560_bib13","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1002\/bit.27157","article-title":"Efficient production of S-adenosyl-l-methionine from dl-methionine in metabolic engineered Saccharomyces cerevisiae","volume":"116","author":"Liu","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jpba.2024.116560_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2021.733492","article-title":"Yeasts as Biopharmaceutical Production Platforms","volume":"2","author":"Kulagina","year":"2021","journal-title":"Front Fungal Biol."},{"issue":"10","key":"10.1016\/j.jpba.2024.116560_bib15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00449-023-02913-1","article-title":"Genome-scale metabolic model analysis of Pichia pastoris for enhancing the production of S-adenosyl-L-methionine","volume":"46","author":"Subash Chandra Bose","year":"2023","journal-title":"Bioprocess Biosyst. Eng."},{"issue":"4","key":"10.1016\/j.jpba.2024.116560_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/bit.22982","article-title":"Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity","volume":"108","author":"Gao","year":"2011","journal-title":"Biotechnol. Bioeng."},{"issue":"11","key":"10.1016\/j.jpba.2024.116560_bib17","article-title":"A risk-based approach to immunogenicity concerns of therapeutic protein products: Part 1 considering consequences of the immune response to a protein","volume":"17","author":"Rosenberg","year":"2004","journal-title":"BioPharm. Int"},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2213365","article-title":"Technical advancement and practical considerations of LC-MS\/MS-based methods for host cell protein identification and quantitation to support process development","volume":"15","author":"Guo","year":"2023","journal-title":"MAbs"},{"issue":"8","key":"10.1016\/j.jpba.2024.116560_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jpba.2024.116560_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.copbio.2014.06.017","article-title":"Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses","volume":"30","author":"Hogwood","year":"2014","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jpba.2024.116560_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107831","article-title":"Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture","volume":"54","author":"Ha","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jpba.2024.116560_bib22","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Specifications: Test Procedures and Acceptance Criteria for Biotechnological\/Biological Products Q6B, ICH Harmonised Tripartite Guideline (1999) ."},{"key":"10.1016\/j.jpba.2024.116560_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.copbio.2021.06.026","article-title":"Analytics of host cell proteins (HCPs): lessons from biopharmaceutical mAb analysis for Gene therapy products","volume":"71","author":"Bracewell","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jpba.2024.116560_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113256","article-title":"Improved identification of host cell proteins in a protein biopharmaceutical by LC-MS\/MS using the ProteoMiner\u2122 Enrichment Kit","volume":"185","author":"M\u00f6rtstedt","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.jpba.2024.116560_bib25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/19420862.2017.1303023","article-title":"A modular and adaptive mass spectrometry-based platform for support of bioprocess development toward optimal host cell protein clearance","volume":"9","author":"Walker","year":"2017","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1955811","article-title":"Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development","volume":"13","author":"Molden","year":"2021","journal-title":"MAbs"},{"key":"10.1016\/j.jpba.2024.116560_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coche.2018.08.001","article-title":"Challenges to industrial mAb bioprocessing\u2014removal of host cell proteins in CHO cell bioprocesses","volume":"22","author":"Gilgunn","year":"2018","journal-title":"Curr. Opin. Chem. Eng."},{"issue":"3","key":"10.1016\/j.jpba.2024.116560_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202200115","article-title":"Methods for addressing host cell protein impurities in biopharmaceutical product development","volume":"18","author":"Tuameh","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jpba.2024.116560_bib29","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Validation of Analytical Procedures: Text and Methodology Q2 (R2), ICH Harmonised Tripartite Guideline (2022)."},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2183816","article-title":"Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques","volume":"30","author":"Song","year":"2023","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-014-9685-5","article-title":"Recommendations for validation of LC-MS\/MS bioanalytical methods for protein biotherapeutics","volume":"17","author":"Jenkins","year":"2015","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.jpba.2024.116560_bib32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/acs.analchem.9b03952","article-title":"Targeted host cell protein quantification by LC-MRM enables biologics processing and product characterization","volume":"92","author":"Gao","year":"2020","journal-title":"Anal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T07:19:06Z","timestamp":1733037546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524006022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":32,"alternative-id":["S0731708524006022"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116560","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of protein impurities in Ademetionine 1,4-Butanedisulfonate","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116560"}}